Dynavax Technologies



Ebit Zmiana Data
AbbVie USD 5.65B 407M 2025-03
Adma Biologics USD 37.59M 2.05M 2024-12
Amgen USD 3.6B 434M 2025-03
AstraZeneca USD 4.8B 604M 2025-03
Biogen USD 582.8M 61.3M 2025-03
BioMarin Pharmaceutical USD 223.89M 62.49M 2025-03
Bristol-Myers Squibb USD 4.18B 30M 2025-03
Dynavax Technologies USD -1632000 11.71M 2024-12
Gilead Sciences USD 2.89B 221M 2025-03
Glaxosmithkline GBP 1.83B 1.76B 2024-12
Merck USD 5.22B 339M 2024-12
Neurocrine Biosciences USD 142M 41.8M 2024-12
Novartis USD 4.86B 286M 2024-12
Pfizer USD 5.93B 1.31B 2025-03
Regeneron Pharmaceuticals USD 913.7M 661M 2025-03
Roche Holding CHF 11.29B 2.68B 2024-06
Sarepta Therapeutics USD 161.68M 139.48M 2024-12
TG Therapeutics USD 29.95M 17.52M 2024-12
Vertex Pharmaceuticals USD 1.2B 108.8M 2024-12



Dynavax Technologies - Aktualne wartości, dane historyczne, prognozy, statystyki, wykresy i kalendarz ekonomiczny - May 2025.